Cargando…

A Panel of Plasma Biomarkers for Differential Diagnosis of Parkinsonian Syndromes

OBJECTIVE: The aim of our study is to explore the most reliable panel of plasma biomarkers for differential diagnosis of parkinsonian syndromes (PDSs). We selected five kinds of neurodegenerative proteins in plasma: neurofilament light chain (NfL), α-synuclein (α-syn), total tau, β-amyloid 42 (Aβ42)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qi, Li, Zhen, Han, Xiaoxuan, Shen, Xiao, Wang, Fei, Bai, Lipeng, Li, Zhuo, Zhang, Rui, Wang, Yanlin, Zhu, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891509/ https://www.ncbi.nlm.nih.gov/pubmed/35250451 http://dx.doi.org/10.3389/fnins.2022.805953

Ejemplares similares

Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson’s Disease
por: Yang, Xiaoxia, et al.
Publicado: (2022)

A Panel of Plasma Exosomal miRNAs as Potential Biomarkers for Differential Diagnosis of Thyroid Nodules
por: Liang, Meihua, et al.
Publicado: (2020)

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
por: Hansson, Oskar, et al.
Publicado: (2017)

Brain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An Update
por: Rizzo, Giovanni, et al.
Publicado: (2016)

Temporal and spatial variability of dynamic microstate brain network in early Parkinson’s disease
por: Chu, Chunguang, et al.
Publicado: (2023)

Serum biomarker panels for diagnosis of gastric cancer
por: Tong, Weihua, et al.
Publicado: (2016)

Plasma Polyamine Biomarker Panels: Agmatine in Support of Prostate Cancer Diagnosis
por: Coradduzza, Donatella, et al.
Publicado: (2022)

Differential Diagnosis Tool for Parkinsonian Syndrome Using Multiple Structural Brain Measures
por: Ota, Miho, et al.
Publicado: (2013)

The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders
por: Rittman, Timothy, et al.
Publicado: (2013)

Magnetic resonance imaging modalities aid in the differential diagnosis of atypical parkinsonian syndromes
por: Tinaz, Sule
Publicado: (2023)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis
por: Zhou, Xin, et al.
Publicado: (2016)

The Parkinsonian Syndrome : Some Points in Diagnosis and Treatment
por: Critchley, Macdonald
Publicado: (1924)

A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer
por: Matin, Farhana, et al.
Publicado: (2018)

Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
por: Shigekiyo, Taro, et al.
Publicado: (2020)

Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis
por: Xin, Lei, et al.
Publicado: (2017)

Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia
por: Thijssen, Elisabeth H., et al.
Publicado: (2022)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis
por: Xiao, Bin, et al.
Publicado: (2018)

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
por: Zhang, Piao, et al.
Publicado: (2022)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Differentiating atypical parkinsonian syndromes—a way forward?
por: Pfeiffer, Ronald F
Publicado: (2015)

Auxiliary diagnosis of Lung Cancer on the basis of a Serum Protein Biomarker Panel
por: Lu, Qiong, et al.
Publicado: (2021)

A five‐miRNA panel in plasma was identified for breast cancer diagnosis
por: Li, Minghui, et al.
Publicado: (2019)

Identification and Classification of Parkinsonian and Essential Tremors for Diagnosis Using Machine Learning Algorithms
por: Xing, Xupo, et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions
por: Magdalinou, Nadia, et al.
Publicado: (2014)

Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges
por: Dutta, Suman, et al.
Publicado: (2023)

Platelet protein biomarker panel for ovarian cancer diagnosis
por: Lomnytska, Marta, et al.
Publicado: (2018)

Plasma CXCL14 as a Candidate Biomarker for the Diagnosis of Lung Cancer
por: Tian, Peng-Fei, et al.
Publicado: (2022)

Quantitative proteomic biomarkers from extracellular vesicles of human seminal plasma in the differential diagnosis of azoospermia
por: Yao, Liping, et al.
Publicado: (2021)

A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers
por: Lima, Ana Rita, et al.
Publicado: (2020)

Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome
por: Laborde, Carlos M., et al.
Publicado: (2013)

Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT
por: Park, Eunkyung, et al.
Publicado: (2013)

FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice
por: Arnone, Annachiara, et al.
Publicado: (2022)

Significance of clinical symptoms and red flags in early differential diagnosis of Parkinson’s disease and atypical Parkinsonian syndromes
por: Schröter, Nils, et al.
Publicado: (2023)

PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes
por: Schönecker, Sonja, et al.
Publicado: (2019)

Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis
por: Cuenco, Joy, et al.
Publicado: (2018)

Duzhong Fang Attenuates the POMC-Derived Neuroinflammation in Parkinsonian Mice
por: Li, Lili, et al.
Publicado: (2021)

Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes
por: Shin, Dong Hoon, et al.
Publicado: (2006)

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation
por: Angelova, Plamena R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m17ss2fin55bideg7epsplv18j